Biotech Co. Overstated Research Credit, Tax Court Says

By Anna Scott Farrell · May 17, 2023, 6:38 PM EDT

A biotechnology company overstated its research credit for 2014 by improperly excluding clinical testing expenses, the U.S. Tax Court ruled Wednesday, upholding a notice of deficiency from the Internal Revenue Service....

To view the full article, register now.